Enterococci and their role in perinatal pathology

Abstract

Enterococcus are opportunistic bacteria and are members of the normal microflora of the gastrointestinal tract of humans and animals. The prevalence of enterococcal infections in pregnant women is approximately 28 %. Enterococcus, colonizing the urogenital tract pregnant women mostly do not show pathogenic effect, however, it is known that they can lead to the development of such complications of pregnancy as threatened preterm labor, placental insufficiency, hypotrophy of the fetus. Of complications in childbirth most common in premature labor, untimely discharge of amniotic fluid, fetal hypoxia. According to the literature cause of neonatal bacteremia and sepsis in 10 % of cases are enterococcus. Thus, for the prevention of complications of pregnancy, delivery and perinatal outcomes in the allocation of Enterococcus urogenital tract to undergo antibacterial therapy, given the sensitivity to antibiotics.

Keywords

Enterococcus / enterococcal infection / complications of pregnancy and childbirth / perinatal outcomes / colonization of neonatal / intrauterine infection / sepsis / antibiotic therapy

References

[1] Билимова С. И. Характеристика факторов персистенции энтерококков. Журнал микробиологии. 2000; 4: 104-5.

[2] Бондаренко В. М., Мацулевич Т. В. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. М.: ГЭОТАР-Медиа; 2007.

[3] Оганян К. А. Течение и исход беременности при колонизации мочеполового тракта женщин стрептококками группы В и D. Автреф. дис… канд. мед. наук. СПб.; 2008.

[4] Сидоренко С. В. Результаты многоцентрового исследования антибиотикочувствительности энтерококков. Антибиотики и химиотерапия. 1998; 9: 9-17.

[5] Сидоренко С. В. Клиническое значение антибиотикорезистентности грамположительных микроорганизмов. Инфекции и антимикробная терапия. 2003; 2: 3-15.

[6] Бондаренко В. М., Суворов А. Н. Симбиотические энтерококки и проблемы энтерококковой оппортунистической инфекции. Журнал микробиологии. 2008; 3: 14-27.

[7] Berkowitz G. S. Epidemiology of preterm birth. Epidemiol. Rev. 1993; 15: 414-43.

[8] Bonten M. J. Colonisation and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob. Agents Chemother. 1995; 12: 2783-6.

[9] Buchino J. J. Systemic group D streptococcal infection in newborn infants. Am. J. Dis. Child. 1979; 133: 270-3.

[10] Bonadio W. A. Group D streptococcal bacteremia in children. A review of 72 cases in 12 years. Clin. Pediatr. 1993; 32 (1): 20-4.

[11] Christie C. Clinical and molecular epidemiology of enterococcal bacteremia in a pediatric teaching hospital. J. Pediatr. 1994; 125 (3): 392-9.

[12] Coudron P. E. Streptococcus faecium outbreak in a neonatal invasive care unit. J. Clin. Microbiol. 1984; 20: 1044-48.

[13] Dobson S. R. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics. 1990; 85: 165-71.

[14] English B. K. Enterococcal and viridans streptococcal infections. In: Textbook of pediatric infectious diseases. 4th ed. Philadelphia: W. B. Saunders; 1998: 1106-29.

[15] Facklam R. R., Sahw D. F., Teixeira L. M. Enterococcus. In: Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. eds. Manual of Clinical Microbiology. 7th ed. Washington; 1999: 297-306.

[16] Galask R. P. Bacterial attachment to the chorioamniotic membranes. Am. J. Obstet. Gynecol. 1984; 148: 915-28.

[17] Gordts B. Vancomycin-resistant enterococci colonising the intestinal tracts of hospitalised patients. J. Inf. Dis. 1995; 11: 2842-6.

[18] Gibbs R. S. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J. Infect. Dis. 1982; 145: 1-8.

[19] Jordens J. Z. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 1994; 34: 515-28.

[20] Koneman E. W. et al. Color atlas and textbook of diagnostic microbiology. N. Y.; 1997.

[21] Larsen H. S. Streptococcaceae. In: Mahon C. R., Manuselis G. Textbook of diagnostic Microbiology. 2 ed. Philadelphia: W. B. Saunders; 2000: 345-58.

[22] Moellering R. C. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell G. L., Bennett J. E., Dolin R. eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000: 2147-56.

[23] Miedema C. J. Risk factors for colonization with enterococci in a neonatal intensive care unit. Clin. Microbiol. Infect. Dis. 2000; 6: 53.

[24] McCarthy A. E. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J. Clin. Microbiol. 1994; 11: 2671-6.

[25] McDonald H. R. Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor? Infect. Dis. Obstet. Gynecol. 2000; 8: 220-7.

[26] Murray B. E. The life and times of Enterococcus. Clin. Microbiol. 1990; 3: 46-65.

[27] Murray B. E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 2000; 342 (10): 710-21.

[28] Murray B. E. Enterococci: new aspects of an old organism. Proc. Assoc. Am. Physicians. 1999; 111 (4): 328-34.

[29] Miller M. B. Prevalence of Vancomycin - Resistant Enterococcus in Prenatal Screening Cultures. J. Clin. Microbiol. 2004; 42 (2): 855-7.

[30] Martines-Martinez L. Activity of eight fluoroquinolones against enterococci. Clin. Microbiol. Infect. 1997; 3: 497-9.

[31] Nyhan W. L. Septicemia of the newborn. Pediatrics. 1958; 22: 268-78.

[32] O’Driscoll T., Crank C. W. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection and Drug Resistance. 2015; 8: 217-30.

[33] Pallares R. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. Arch. Intern. Med. 1993;153: 1581-6.

[34] Romero R. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 1989; 161; 817-24.

[35] Sahm D. F. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis. J. Clin. Microbiol. 1984; 20: 561-7.

[36] Stoll B. J., Hansen N., Fanaroff A. A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 2002; 347: 240-7.

[37] Wenger J. D., Hightower A. W., Facklam R. R., Gaventa S., Broome C. V. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J. Infect. Dis. 1990; 162: 1316-23.

RIGHTS & PERMISSIONS

Oganyan K.A., Arzhanova O.N., Zatsiorskaya S.L., Savicheva A.M.